The bariatric beds market is expected to increase from USD 297.08 million in 2023 to USD 497.92 million in 2033. The market is likely to capture a 5.3% CAGR from 2023 to 2033.
The Increase in Global Obesity is driving the need for Bariatric Beds
Factors that are expected to drive market expansion include:
Bariatrics is a specialty of medicine that treats persons who are overweight. The key parameters involved in determining a bariatric patient are the patient's weight and the overall distribution of weight throughout the body.
Obese patients are typically identified with the help of the Body Mass Index (BMI). Many hospitals are now embracing bariatrics as a separate specialty. A bariatric bed is specifically built to meet the needs and comfort of obese individuals.
Bariatric beds have extensive obligation outlines, a high weight capacity, and several movable highlights for the comfort and flexibility of the patient. Increasing health concerns such as heart disease have motivated people to seek bariatric surgery. The worldwide bariatric beds market is likely to be driven by improved patient experience and comfort.
| Report Attribute | Details |
|---|---|
| Bariatric Beds Market Value (2023) | USD 297.08 million |
| Bariatric Beds Market Anticipated Value (2033) | USD 497.92 million |
| Bariatric Beds Market Growth Rate (2023 to 2033) | 5.3% CAGR |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The bariatric beds market accounted for USD 282.13 million in 2022, expanding at a 5% CAGR from 2018 to 2022.
Sedentary lifestyles, greater consumption of unhealthy foods, an increase in bariatric surgery, and rare genetic diseases leading to obesity. Prader-Willi syndrome, hypothyroidism, and Cushing's syndrome are among the causes driving growth in the worldwide bariatric beds market.
Furthermore, the rising obesity rate is expected to fuel the worldwide bariatric beds market. According to the World Health Organization (WHO), an estimated 650 million people worldwide were obese in 2016. These figures also revealed that an estimated 1.9 billion individuals worldwide were overweight, adding to the demand for bariatric beds.
High initial acquisition costs of bariatric beds, combined with higher maintenance costs, are important issues that can stymie the global bariatric beds market's growth.
Increasing demand for preoperative and postoperative bariatric procedures, increased use of current technology, and expansion of healthcare infrastructure are expected to drive market growth soon. Rising approval and product launch are two more elements that can drive market expansion. Hefty maintenance costs and early acquisition costs can stifle market growth.
| Historical CAGR (2018 to 2022) | 5% |
|---|---|
| Forecast CAGR (2023 to 2033) | 5.3% |
As per the FMI analysts, a valuation of USD 497.92 million by 2033 end is estimated for the market.
| Year | Market Valuation |
|---|---|
| 2016 | USD 206.95 million |
| 2021 | USD 267.93 million |
| 2022 | USD 282.13 million |
| 2023 | USD 297.08 million |
| 2033 | USD 497.92 million |
The rising consumption of unhealthy foods is expected to boost the worldwide bariatric beds' industry. Increasing sedentary lifestyle adoption, as well as an increase in bariatric operations, are expected to support the growth of the market. Additionally, the rising obesity rate is likely to raise the bariatric bed market share.
Bariatric surgery was always seen to be a last resort for weight loss; nevertheless, it has grown in popularity over the years. Since it is safer and more effective than normal medical procedures, such as drugs and dietary counseling. Over the last decade, several bariatric surgeries performed worldwide have steadily increased.
The overall count of bariatric procedures performed in the United States was 158,000 in 2011, according to the American Society for Metabolic and Bariatric Surgery (ASMBS). The rise in bariatric operations is predicted to increase demand for associated equipment and gadgets. Following this, bariatric surgery is the most effective and long-term treatment for morbid obesity and a variety of linked illnesses.
Obesity is still a big public health issue around the world. Those with obesity incurred medical costs that were USD 1,861 more than those with a healthy weight. Bariatric surgery is an effective treatment for extreme obesity. Resulting in the improvement or remission of many obesity-related comorbid disorders, long-term weight loss, and overall enhanced quality of life.
Developing markets such as India and South Korea are working hard to establish a regulatory framework. This framework distinguishes between medical devices and pharmaceutical devices and instruments. Because there is no clear separation between medications and devices, the clearance process is currently unstable, resulting in delays. As a result, unstable regulatory frameworks are projected to lengthen the clearance process for surgical equipment.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Laparoscopic or minimally invasive bariatric surgery has many advantages, including fewer wound complications, shorter hospital stays, and less pain. Internal hernias, gastroesophageal reflux disease (GERD), chronic nausea and vomiting, severe dumping syndrome, ulcers, malnutrition, and inflammatory bowel disease are all risks linked with these operations.
A gastric balloon, also known as an intragastric balloon (IGB) or a stomach balloon, is a temporary medical device that is put into the stomach to aid with weight loss. Factors such as:
The ReShape Duo Balloon and the ORBERA Balloon are two approved gastric balloons in the United States. Spatz Medical said in May 2019 that their newly launched Spatz3 balloon is much more successful than any non-adjustable balloon, as determined by the USFDA. Nonetheless, market participants have used a variety of techniques, including funding and product launch processes.
Allurion Technologies, a manufacturer of gastric weight-loss balloons, has boosted its funding by USD 34 million to speed its commercialization efforts and entry into the United States market for its Elipse Balloon. As a result, the gastric balloon segment is predicted to grow.
The rising incidence of chronic conditions such as diabetes, in North America, is likely to lead the worldwide bariatric beds market during the forecast period. The increased acceptance of unhealthy lifestyles is also expected to boost the region's market.
According to the Centres for Disease Control and Prevention (CDC), 39.8% of the United States population, or 93.3 million people, were obese in 2015 to 2016.
Increasing life expectancy in this region is predicted to increase demand for home healthcare and long-term care services, driving the market in North America. Moreover, factors that are likely to drive the market growth include:
Increasing healthcare expenditure in this region is likely to drive technical developments in the healthcare market. Advantageous reimbursement rules and increased government spending in long-term healthcare. Additionally, expanding infrastructure for healthcare research is among the variables that are predicted to increase the use of bariatric beds.
Due to an increase in many bariatric operations, the bariatric beds market in Europe is likely to develop throughout the forecast period. According to the National Bariatric Surgery Registry, 5,704 bariatric surgeries were reported in the United Kingdom between 2015 and 2016.
Throughout the projection period, Asia Pacific is expected to have the highest growth rate of 6.0%. The increased prevalence of chronic diseases is a result of bad eating habits, excessive cigarette smoking, and the rising need for cost-effective treatments. Furthermore, with rapidly increasing purchasing power, a higher proportion of the population pays for its healthcare needs and lavishes money on technologically improved healthcare services.
The rising prevalence of dyslipidemia. The rise in the incidence of type 2 diabetes mellitus, lack of physical exercise, and rise in the obese population are all positively impacting the Asia Pacific global bariatric beds market. Because of substantial public and private research expenditures and the availability of technologically advanced items.
In 2022, the 500-700 lbs category led the market, accounting for more than 41% of the total. Bariatric beds with weight capacities of 500-700 lbs are more comfortable and can accommodate more prospective patients. Additionally, 500-700-pound bariatric beds allow for customizable placement, which significantly modifies the bed's construction. As an added benefit, side rails prevent patients from collapsing during surgical operations or while exiting or entering the bed. As a result, increased benefits associated with 500-700 lbs bariatric beds, as well as an increase in its adoption rate, are likely to fuel industry growth.
In 2022, the hospital segment led the end-use segment. When compared to other healthcare settings, hospitals see a substantially higher influx of patients for a variety of surgeries. This includes bariatric surgery, due to the simplicity of managing any emergencies that may develop during surgical procedures. Moreover, the availability of a wide range of treatment alternatives.
This is due to an increase in the obese population, an increase in the demand for bariatric surgery for preoperative and postoperative procedures, and skilled staff.
To maintain their market position, several firms in the bariatric beds market are pursuing various growth strategies such as strategic partnerships and collaborations, product approval and launches, mergers and acquisitions, and joint ventures. Because the leading market participants are spending on research and development to develop cost-effective and efficient bariatric beds, the industry is competitive.
| Attribute | Details |
|---|---|
| Market Size Value in 2023 | USD 297.08 million |
| Market Size Value at End of Forecast (2033) | USD 497.92 million |
| Market Analysis | USD million for Value |
| Key Region Covered | North America; Europe; Asia Pacific; Latin America; The Middle East & Africa |
| Key Segments | By Weight Capacity, By End Use, By Region |
| Key Companies Profiled | Invacare Corporation; Hill-Rom holdings; Stryker; Arjo; Drive DeVilbiss Healthcare; Gf Health Products; Zhangjiagang Medi; Cobi Rehab; Alerta; Rotec International |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The expansion in the elderly population drives sales.
North America is anticipated to be the market with the high potential.
The market is forecast to register a CAGR of 5.3% through 2033.
The market is valued at USD 297.08 million in 2023.
The introduction of bariatric patient mattresses boosts the industry's revenue.
| Estimated Market Size (2024E) | USD 1,850.3 million |
|---|---|
| Projected Market Value (2034F) | USD 3,440.8 million |
| Value-based CAGR (2024 to 2034) | 6.4% |
| Market Value (2022) | USD 2,453.72 Million |
|---|---|
| Market Forecast Value (2032) | USD 5,297.39 Million |
| Market CAGR (2022 to 2032) | 8% |
Explore Hospital Furniture Insights
View Reports
Bariatric Beds Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
